Protagen AG collaborates with UCSF to study better immuno-profiling of cancer patients receiving immunotherapy
Protagen AG has announced the start of a collaboration with the University of California, San...
The Falsified Medicines Directive – are you ready?
The Falsified Medicines Directive 2011/62/EU, which is due for adoption in February 2019, will require...
Stem Cell and Regenerative Therapies for Hearing Loss
The year 2018 marks a notable milestone in the history of stem cell and regenerative...
High quality ophthalmic consumables at affordable prices to developing countries: An Aurolabs Case Study
Aurolab, the manufacturing division of Aravind Eye Hospital, at Madurai, Tamil Nadu that supplies high...
Organovo Receives Orphan Designation From U.S. FDA for 3D Bioprinted Therapeutic Liver Tissue Treatment...
Organovo Holdings, Inc announced that the U.S. FDA granted orphan drug designation for the Company’s...
Second Sartorius Research Xchange Forum Focuses On Regenerative Medicine and Cell Therapy
Promoting interdisciplinary exchange between science and industry on the topics of regenerative medicine and cell...
Mount Sinai Researchers Identify Novel Therapeutic Targets for Metastatic Melanoma, Path for New Drugs
Mount Sinai researchers have identified novel therapeutic targets for metastatic melanoma, according to a study...
InVitria Announces New Media Formulation Service
InVitria, a division of Ventria Bioscience, has announced the launch of a new media formulation...
Auditory Therapy, Ototoxicity and GLP Compliance Will the promising market for ear disorder treatments...
The numbers are daunting – 15% of the global population suffers from hearing loss, including...
Nativis’ platform aims to transform disease treatment on a global scale – “a symphony...
In late 2015, I was approached by the board of Nativis, Inc.to take on the...
